Yigal Nochomovitz
Stock Analyst at Citigroup
(3.33)
# 1,031
Out of 4,996 analysts
308
Total ratings
45.31%
Success rate
3.65%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yigal Nochomovitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVBP ArriVent BioPharma | Maintains: Buy | $40 → $33 | $18.03 | +83.03% | 3 | Aug 12, 2025 | |
| ARCT Arcturus Therapeutics Holdings | Maintains: Buy | $47 → $49 | $22.17 | +121.02% | 6 | Aug 12, 2025 | |
| OLMA Olema Pharmaceuticals | Maintains: Buy | $20 → $21 | $9.51 | +120.82% | 2 | Aug 12, 2025 | |
| ZLAB Zai Lab | Maintains: Buy | $66 → $69 | $31.62 | +118.22% | 9 | Aug 11, 2025 | |
| BMEA Biomea Fusion | Maintains: Buy | $9 → $7 | $2.10 | +233.33% | 10 | Aug 11, 2025 | |
| ZYME Zymeworks | Maintains: Buy | $19 → $22 | $16.60 | +32.53% | 17 | Aug 11, 2025 | |
| LXRX Lexicon Pharmaceuticals | Maintains: Buy | $1.2 → $1.9 | $1.40 | +35.71% | 12 | Aug 7, 2025 | |
| SNDX Syndax Pharmaceuticals | Maintains: Buy | $46 → $51 | $15.68 | +225.26% | 9 | Aug 5, 2025 | |
| KRYS Krystal Biotech | Maintains: Neutral | $176 → $166 | $167.82 | -1.08% | 6 | Aug 5, 2025 | |
| APLS Apellis Pharmaceuticals | Maintains: Buy | $46 → $52 | $22.39 | +132.25% | 17 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $49 → $52 | $42.03 | +23.72% | 4 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $7 | $18.36 | -61.87% | 1 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $2.49 | +261.45% | 2 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $6.15 | +127.64% | 1 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $9.5 | $8.27 | +14.87% | 10 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $5.54 | +80.51% | 15 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $23 → $35 | $20.95 | +67.06% | 5 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $49 → $55 | $28.63 | +92.11% | 11 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $5.54 | +351.26% | 1 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $82 | $61.67 | +32.97% | 21 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $13.90 | +137.41% | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $97 | $68.89 | +40.80% | 16 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $8 | $1.24 | +545.16% | 10 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $6 | $2.13 | +181.69% | 5 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $20.04 | +34.73% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $8 → $2 | $2.28 | -12.28% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $58 | $26.83 | +116.18% | 3 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $1.73 | +709.25% | 14 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.5 → $1.2 | $1.73 | -30.64% | 9 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $38 | $12.84 | +195.95% | 7 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $14 | $11.12 | +25.90% | 6 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.8 → $2 | $2.11 | -5.21% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $8 | $5.07 | +57.79% | 10 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1 | $5.26 | -80.99% | 4 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $50 → $35 | $13.74 | +154.73% | 12 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $133 | $29.08 | +357.36% | 15 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $16 | $3.32 | +381.93% | 3 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $1.00 | +900.00% | 6 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $44 | $3.41 | +1,190.32% | 2 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $1.78 | +574.16% | 1 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $4.84 | - | 14 | Sep 28, 2021 |
ArriVent BioPharma
Aug 12, 2025
Maintains: Buy
Price Target: $40 → $33
Current: $18.03
Upside: +83.03%
Arcturus Therapeutics Holdings
Aug 12, 2025
Maintains: Buy
Price Target: $47 → $49
Current: $22.17
Upside: +121.02%
Olema Pharmaceuticals
Aug 12, 2025
Maintains: Buy
Price Target: $20 → $21
Current: $9.51
Upside: +120.82%
Zai Lab
Aug 11, 2025
Maintains: Buy
Price Target: $66 → $69
Current: $31.62
Upside: +118.22%
Biomea Fusion
Aug 11, 2025
Maintains: Buy
Price Target: $9 → $7
Current: $2.10
Upside: +233.33%
Zymeworks
Aug 11, 2025
Maintains: Buy
Price Target: $19 → $22
Current: $16.60
Upside: +32.53%
Lexicon Pharmaceuticals
Aug 7, 2025
Maintains: Buy
Price Target: $1.2 → $1.9
Current: $1.40
Upside: +35.71%
Syndax Pharmaceuticals
Aug 5, 2025
Maintains: Buy
Price Target: $46 → $51
Current: $15.68
Upside: +225.26%
Krystal Biotech
Aug 5, 2025
Maintains: Neutral
Price Target: $176 → $166
Current: $167.82
Upside: -1.08%
Apellis Pharmaceuticals
Aug 1, 2025
Maintains: Buy
Price Target: $46 → $52
Current: $22.39
Upside: +132.25%
Aug 1, 2025
Maintains: Buy
Price Target: $49 → $52
Current: $42.03
Upside: +23.72%
Jul 24, 2025
Initiates: Sell
Price Target: $7
Current: $18.36
Upside: -61.87%
Jul 9, 2025
Maintains: Buy
Price Target: $6 → $9
Current: $2.49
Upside: +261.45%
Jun 26, 2025
Initiates: Buy
Price Target: $14
Current: $6.15
Upside: +127.64%
May 5, 2025
Maintains: Neutral
Price Target: $10 → $9.5
Current: $8.27
Upside: +14.87%
May 2, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $5.54
Upside: +80.51%
Mar 26, 2025
Upgrades: Buy
Price Target: $23 → $35
Current: $20.95
Upside: +67.06%
Mar 6, 2025
Maintains: Buy
Price Target: $49 → $55
Current: $28.63
Upside: +92.11%
Feb 20, 2025
Initiates: Buy
Price Target: $25
Current: $5.54
Upside: +351.26%
Feb 18, 2025
Maintains: Buy
Price Target: $89 → $82
Current: $61.67
Upside: +32.97%
Jan 7, 2025
Initiates: Buy
Price Target: $33
Current: $13.90
Upside: +137.41%
Dec 9, 2024
Maintains: Buy
Price Target: $89 → $97
Current: $68.89
Upside: +40.80%
Nov 29, 2024
Maintains: Buy
Price Target: $13 → $8
Current: $1.24
Upside: +545.16%
Nov 26, 2024
Maintains: Buy
Price Target: $30 → $6
Current: $2.13
Upside: +181.69%
Oct 8, 2024
Initiates: Buy
Price Target: $27
Current: $20.04
Upside: +34.73%
Oct 2, 2024
Downgrades: Neutral
Price Target: $8 → $2
Current: $2.28
Upside: -12.28%
Aug 27, 2024
Maintains: Buy
Price Target: $60 → $58
Current: $26.83
Upside: +116.18%
Aug 15, 2024
Maintains: Buy
Price Target: $16 → $14
Current: $1.73
Upside: +709.25%
Jun 18, 2024
Maintains: Neutral
Price Target: $3.5 → $1.2
Current: $1.73
Upside: -30.64%
Jun 3, 2024
Maintains: Buy
Price Target: $36 → $38
Current: $12.84
Upside: +195.95%
May 7, 2024
Maintains: Buy
Price Target: $15 → $14
Current: $11.12
Upside: +25.90%
Apr 18, 2024
Maintains: Neutral
Price Target: $1.8 → $2
Current: $2.11
Upside: -5.21%
Oct 17, 2023
Maintains: Buy
Price Target: $25 → $8
Current: $5.07
Upside: +57.79%
Sep 18, 2023
Maintains: Neutral
Price Target: $1.5 → $1
Current: $5.26
Upside: -80.99%
Aug 21, 2023
Maintains: Sell
Price Target: $50 → $35
Current: $13.74
Upside: +154.73%
Jun 7, 2023
Maintains: Buy
Price Target: $130 → $133
Current: $29.08
Upside: +357.36%
Apr 5, 2023
Maintains: Buy
Price Target: $24 → $16
Current: $3.32
Upside: +381.93%
Mar 2, 2023
Maintains: Buy
Price Target: $9 → $10
Current: $1.00
Upside: +900.00%
Sep 16, 2022
Maintains: Buy
Price Target: $45 → $44
Current: $3.41
Upside: +1,190.32%
Sep 16, 2022
Maintains: Buy
Price Target: $16 → $12
Current: $1.78
Upside: +574.16%
Sep 28, 2021
Upgrades: Buy
Price Target: n/a
Current: $4.84
Upside: -